Related Experiment Video

Updated: May 16, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Extended adjuvant tamoxifen for breast cancer--a new era?

Trevor J Powles

    Lancet (London, England)
    |December 11, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
    10:39

    Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

    Published on: June 18, 2015

    Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
    03:07

    Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

    Published on: August 19, 2025

    Related Experiment Videos

    Last Updated: May 16, 2026

    Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
    19:44

    Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

    Published on: May 30, 2012

    Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
    10:39

    Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

    Published on: June 18, 2015

    Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
    03:07

    Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

    Published on: August 19, 2025

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

    Articles linked to this work by shared authors, journal, and citation graph.

    Immunohistochemical Phenotype of Breast Cancer during 25-Year Follow-up of the Royal Marsden Tamoxifen Prevention Trial.

    Cancer prevention research (Philadelphia, Pa.)·2017

    Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2016

    Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trials.

    Breast cancer research and treatment·2016

    Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene.

    Breast cancer research and treatment·2012

    Prevention of breast cancer using SERMs.

    Advances in experimental medicine and biology·2008

    Red clover isoflavones are safe and well tolerated in women with a family history of breast cancer.

    Menopause international·2008

    Perioperative durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable gastric and gastro-oesophageal junction adenocarcinoma (MATTERHORN): final results of overall survival and event-free survival by pathological response in a global, randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

    Lancet (London, England)·2026

    Wildfire smoke and health: current evidence, mechanisms, and future challenges.

    Lancet (London, England)·2026

    Use of the bacterial lysate OM-85 for the primary prevention of wheezing lower respiratory illness in preschool children: a randomised, placebo-controlled trial.

    Lancet (London, England)·2026

    Wealth redistribution policies to mitigate the impact of development assistance defunding: a retrospective evaluation and forecasting analysis up to 2030.

    Lancet (London, England)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us